Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 91–105 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3920 BBS1 Gene Bardet-Biedl Syndrome Type 1 Genetic Test (NGS) This test analyzes the BBS1 gene using Next Generation Sequencing (NGS) to detect pathogenic variants associated with Bardet-Biedl Syndrome Type 1.	Whole Blood (Peripheral) or Extracted DNA / FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BBS1 gene", "Missense variants", "Nonsense variants", "Frameshift variants", "Splice-site variants", "Deep intronic variants"] Parameters [] Preparation ["No special dietary or medication preparation is needed", "Continue all prescribed therapies unless advised otherwise by your physician"] Indications ["Suspected Bardet-Biedl Syndrome Type 1", "Family history of Bardet-Biedl Syndrome Type 1", "Need for genetic counselling regarding BBS1-related risks"] Measurement technique Confirm with laboratory Codes LOINC: 94267-3 ICD-10: Q87.8 Clinical summary This test analyzes the BBS1 gene using Next Generation Sequencing (NGS) to detect pathogenic variants associated with Bardet-Biedl Syndrome Type 1.
TEST-3958 BBS12 Gene (Bardet-Biedl Syndrome Type 12) Genetic Test This test identifies pathogenic variants in the BBS12 gene to confirm a diagnosis of Bardet-Biedl syndrome type 12.	Whole Blood (EDTA), Extracted DNA, Dried Blood Spot (FTA Card)	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BBS12 gene"] Parameters [] Preparation ["Fasting is not required", "Pre-test genetic counselling is mandatory"] Indications ["Diagnosis of Bardet-Biedl syndrome type 12", "Carrier detection in at-risk family members", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 103204-9 ICD-10: Q87.89 Clinical summary This test identifies pathogenic variants in the BBS12 gene to confirm a diagnosis of Bardet-Biedl syndrome type 12.
TEST-3898 BBS5 Gene Bardet-Biedl Syndrome Type 5 Genetic Test This test identifies pathogenic variants in the BBS5 gene associated with Bardet-Biedl syndrome type 5.	Peripheral blood (EDTA), extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BBS5 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["Pre-genetic counselling session required", "Completed clinical history form required"] Indications ["Individuals with suggestive clinical features of Bardet-Biedl syndrome type 5", "Family history of ciliopathies", "Pre-test genetic counseling recommended"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Q87.89 Clinical summary This test identifies pathogenic variants in the BBS5 gene associated with Bardet-Biedl syndrome type 5.
TEST-6093 BCKDHA Gene Maple Syrup Urine Disease Type 1a Genetic Test This test identifies pathogenic variants in the BCKDHA gene associated with Maple Syrup Urine Disease Type 1a.	Peripheral Whole Blood or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCKDHA gene pathogenic variants", "Single nucleotide variants", "Small insertions and deletions", "Copy-number changes"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session", "Do not discontinue prescribed medication or initiate a leucine-restricted diet without physician supervision"] Indications ["Suspected Maple Syrup Urine Disease Type 1a", "Carrier screening", "Family cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 21629-5 ICD-10: E71.0 Clinical summary This test identifies pathogenic variants in the BCKDHA gene associated with Maple Syrup Urine Disease Type 1a.
TEST-6047 BCKDK Gene Genetic Test for Branched-Chain Ketoacid Dehydrogenase Kinase Deficiency This test identifies genetic mutations in the BCKDK gene associated with branched-chain ketoacid dehydrogenase kinase deficiency.	Whole blood, extracted DNA, or dried blood spot (FTA card)	3-4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCKDK gene sequence", "Pathogenic variants in BCKDK gene"] Parameters [] Preparation ["Inform laboratory of recent blood transfusion (within 4 weeks)", "Notify phlebotomist if on anticoagulant therapy"] Indications ["Diagnosis of BCKDK deficiency", "Carrier screening", "Prenatal testing", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 92737-7 ICD-10: E71.1 Clinical summary This test identifies genetic mutations in the BCKDK gene associated with branched-chain ketoacid dehydrogenase kinase deficiency.
TEST-1836 BCL6 Gene Rearrangement (FISH) Test This test detects chromosomal rearrangements of the BCL6 gene using Fluorescence In-Situ Hybridization (FISH). It is a key molecular marker for classifying and understanding B-cell...	Bone marrow aspirate or peripheral whole blood	5–6 working days	900.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCL6 gene rearrangements", "Chromosomal translocations at 3q27"] Parameters [] Preparation ["No special fasting required"] Indications ["Classification of B-cell lymphomas", "Prognostic assessment in lymphoma", "Guiding targeted therapy decisions"] Measurement technique Confirm with laboratory Codes LOINC: 49583-7 ICD-10: C83.9 Clinical summary This test detects chromosomal rearrangements of the BCL6 gene using Fluorescence In-Situ Hybridization (FISH). It is a key molecular marker for classifying and understanding B-cell lymphomas.
TEST-5157 BCS1L Gene Mitochondrial Complex III Deficiency Genetic Test This genetic test evaluates the BCS1L gene for pathogenic variants associated with mitochondrial complex III deficiency.	Peripheral whole blood (EDTA) or buccal swab	12–18 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCS1L gene coding sequence", "Single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Exon-level copy number variants (CNVs)"] Parameters [] Preparation ["A detailed clinical history is required.", "A formal genetic counselling session to draw a pedigree chart is mandatory."] Indications ["Suspected mitochondrial complex III deficiency", "Neonatal-onset encephalopathy", "Hepatopathy", "Renal tubulopathy"] Measurement technique Confirm with laboratory Codes LOINC: 93336-6 ICD-10: E88.49, G31.81 Clinical summary This genetic test evaluates the BCS1L gene for pathogenic variants associated with mitochondrial complex III deficiency.
TEST-5733 BICD2 Gene Sequencing for Spinal Muscular Atrophy, Lower Extremity, Autosomal Dominant Type 2 (NGS) Test This diagnostic test evaluates the BICD2 gene for pathogenic variants associated with autosomal dominant lower extremity spinal muscular atrophy type 2.	Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BICD2 gene sequence", "Pathogenic variants in BICD2"] Parameters [] Preparation ["No special preparation needed"] Indications ["Suspected lower extremity-predominant spinal muscular atrophy type 2", "Family history of autosomal dominant spinal muscular atrophy"] Measurement technique Confirm with laboratory Codes LOINC: 95277-6 ICD-10: G12.1 Clinical summary This diagnostic test evaluates the BICD2 gene for pathogenic variants associated with autosomal dominant lower extremity spinal muscular atrophy type 2.
TEST-3343 BLNK Gene Agammaglobulinemia Type 4 (Autosomal Recessive) Genetic Test This genetic test identifies pathogenic mutations in the BLNK gene associated with autosomal recessive agammaglobulinemia.	Blood (EDTA), Extracted DNA, or One Drop Blood on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BLNK gene sequence", "Pathogenic mutations in BLNK gene"] Parameters [] Preparation [] Indications ["Suspected autosomal recessive agammaglobulinemia", "Recurrent sinopulmonary infections", "Pan-hypogammaglobulinemia with absent B cells", "Carrier screening in affected families", "Preimplantation genetic testing guidance"] Measurement technique Confirm with laboratory Codes LOINC: 94853-7 ICD-10: D80.0 Clinical summary This genetic test identifies pathogenic mutations in the BLNK gene associated with autosomal recessive agammaglobulinemia.
TEST-4724 BMP1 Gene Osteogenesis Imperfecta Type 13 Genetic Test This test evaluates the BMP1 gene for pathogenic variants associated with Osteogenesis Imperfecta Type 13.	Peripheral Whole Blood or Sterile DNA FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BMP1 gene pathogenic variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation [] Indications ["Suspected Osteogenesis Imperfecta Type 13", "Differentiation from other collagenopathies", "Genetic skeletal disorder diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 93025-1 ICD-10: Q78.0 Clinical summary This test evaluates the BMP1 gene for pathogenic variants associated with Osteogenesis Imperfecta Type 13.
TEST-3047 BMP2 Gene Brachydactyly Type A2 Genetic Test This test identifies pathogenic variants within the BMP2 gene associated with autosomal dominant brachydactyly type A2.	Peripheral Whole Blood (EDTA) or DNA FTA Card	3–4 Weeks (21–28 Business Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BMP2 gene variants", "Single nucleotide variants", "Small indels", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Clinical suspicion of brachydactyly type A2", "Family history of brachydactyly", "Need for genetic counseling regarding recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 82316-9 ICD-10: Q68.1 Clinical summary This test identifies pathogenic variants within the BMP2 gene associated with autosomal dominant brachydactyly type A2.
TEST-1911 BMPR1A Gene Hereditary Mixed Polyposis Syndrome Type 2 (HMPS2) Genetic Test This genetic test evaluates the BMPR1A gene for pathogenic variants associated with Hereditary Mixed Polyposis Syndrome Type 2 (HMPS2), a condition increasing colorectal cancer ris...	Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BMPR1A gene sequence", "Copy Number Variants (CNVs) in BMPR1A"] Parameters [] Preparation ["No fasting required", "Complete pre-genetic counselling session", "Sign informed consent"] Indications ["Personal or family history of multiple and/or mixed gastrointestinal polyps", "Early-onset colorectal cancer", "Known familial BMPR1A mutation"] Measurement technique Confirm with laboratory Codes LOINC: 21634-2 ICD-10: Z15.09 Clinical summary This genetic test evaluates the BMPR1A gene for pathogenic variants associated with Hereditary Mixed Polyposis Syndrome Type 2 (HMPS2), a condition increasing colorectal cancer risk.
TEST-5232 BOLA3 Gene-MMDS2 Genetic Test This test analyzes the BOLA3 gene for pathogenic variants associated with Multiple Mitochondrial Dysfunctions Syndrome Type 2 (MMDS2). It uses Next Generation Sequencing (NGS) to c...	Peripheral whole blood (EDTA) or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BOLA3 gene", "Coding exons ± 20 bp intronic boundaries of the BOLA3 gene"] Parameters [] Preparation ["No specific fasting required.", "No medication or diet modifications needed prior to sample collection."] Indications ["Definitive diagnosis of MMDS2", "Carrier screening for MMDS2", "Informed family planning", "Differential diagnosis of mitochondrial encephalomyopathies"] Measurement technique Confirm with laboratory Codes LOINC: 89588-6 ICD-10: G31.89 Clinical summary This test analyzes the BOLA3 gene for pathogenic variants associated with Multiple Mitochondrial Dysfunctions Syndrome Type 2 (MMDS2). It uses Next Generation Sequencing (NGS) to cover the entire coding region.
TEST-4363 BRAF Gene Cardiofaciocutaneous Syndrome Genetic Test This test evaluates the entire coding region of the BRAF gene for pathogenic variants associated with Cardiofaciocutaneous Syndrome (CFC). It uses Next-Generation Sequencing (NGS)...	Peripheral Whole Blood or Buccal Swab (DNA Extraction)	3–4 Weeks (expedited processing available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BRAF gene coding region variants", "Pathogenic mutations associated with CFC"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications"] Indications ["Suspected Cardiofaciocutaneous Syndrome (CFC)", "RASopathy suspected with negative prior testing", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 81263-1 ICD-10: Q87.89 Clinical summary This test evaluates the entire coding region of the BRAF gene for pathogenic variants associated with Cardiofaciocutaneous Syndrome (CFC). It uses Next-Generation Sequencing (NGS) with Sanger confirmation.
TEST-6067 BSCL2 Gene Lipodystrophy Generalized Type 2 Genetic Test This test evaluates the BSCL2 gene for pathogenic variants associated with congenital generalized lipodystrophy type 2.	Peripheral whole blood (3–5 mL EDTA) or FTA card	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BSCL2 gene", "Coding region and splice-site variants", "SNVs, indels, and splice-site variants down to 5% heteroplasmy"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed metabolic therapy without consulting physician"] Indications ["Patients presenting with severe insulin resistance", "Patients with hypertriglyceridemia", "Patients with early-onset metabolic complications", "Suspected congenital generalized lipodystrophy type 2"] Measurement technique Confirm with laboratory Codes LOINC: 21659-0 ICD-10: E88.1 Clinical summary This test evaluates the BSCL2 gene for pathogenic variants associated with congenital generalized lipodystrophy type 2.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.